In addition to the pain they inflict on individuals, noncommunicable diseases take a heavy economic toll on entire countries. When people die prematurely or become disabled, the losses spiral outward into society, resulting in lower productivity and missed opportunities. Research by the World Economic Forum and Harvard School of Public Health estimates that low- and middle-income countries lose $500 billion per year in economic output because of the cumulative effects of NCDs.
Helping these countries prevent and treat NCDs, then, is a critical development strategy. Working with partners around the globe, we bring extensive knowledge of health economics, budgeting, and financing to these efforts.
We have analyzed interventions and prevention programs aimed at specific conditions, including diabetes, cardiovascular disease, and chronic kidney disease. We have also helped nationwide health systems enact broad reforms that ensure efficiency and sound budgeting.